was read the article
array:24 [ "pii" => "S217357431300138X" "issn" => "21735743" "doi" => "10.1016/j.reumae.2013.12.007" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "598" "copyright" => "Elsevier España, S.L.. All rights reserved" "copyrightAnyo" => "2013" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2014;10:196-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1742 "formatos" => array:3 [ "EPUB" => 54 "HTML" => 1382 "PDF" => 306 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X13001812" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2013.05.011" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "598" "copyright" => "Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2014;10:196-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5259 "formatos" => array:3 [ "EPUB" => 196 "HTML" => 3994 "PDF" => 1069 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Reactivación del virus de la hepatitis B en un paciente con artritis reumatoide tras el tratamiento con rituximab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "196" "paginaFinal" => "197" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Reactivation of hepatitis virus B infection in a patient with rheumatoid arthritis after treatment with rituximab" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Tarek Carlos Salman-Monte, María Pilar Lisbona, Montserrat García-Retortillo, Joan Maymó" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Tarek Carlos" "apellidos" => "Salman-Monte" ] 1 => array:2 [ "nombre" => "María Pilar" "apellidos" => "Lisbona" ] 2 => array:2 [ "nombre" => "Montserrat" "apellidos" => "García-Retortillo" ] 3 => array:2 [ "nombre" => "Joan" "apellidos" => "Maymó" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S217357431300138X" "doi" => "10.1016/j.reumae.2013.12.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431300138X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X13001812?idApp=UINPBA00004M" "url" => "/1699258X/0000001000000003/v1_201405040016/S1699258X13001812/v1_201405040016/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574313001366" "issn" => "21735743" "doi" => "10.1016/j.reumae.2013.12.005" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "595" "copyright" => "Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2014;10:197-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2064 "formatos" => array:3 [ "EPUB" => 50 "HTML" => 1452 "PDF" => 562 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Frequency of Gout According to the Perception of Physicians in México" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "197" "paginaFinal" => "198" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Frecuencia de la gota según la percepción de los médicos en México" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 854 "Ancho" => 1641 "Tamanyo" => 60019 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Frequency of rheumatic diseases as perceived by physicians. OA (osteoarthritis), RA (rheumatoid arthritis), FM (fibromyalgia), SLE (systemic lupus erythematosus) and AS (ankylosing spondylitis).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sergio García-Méndez, Roberto Arreguín-Reyes, Omar López-López, Janitzia Vázquez-Mellado" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Sergio" "apellidos" => "García-Méndez" ] 1 => array:2 [ "nombre" => "Roberto" "apellidos" => "Arreguín-Reyes" ] 2 => array:2 [ "nombre" => "Omar" "apellidos" => "López-López" ] 3 => array:2 [ "nombre" => "Janitzia" "apellidos" => "Vázquez-Mellado" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X13001782" "doi" => "10.1016/j.reuma.2013.06.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X13001782?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574313001366?idApp=UINPBA00004M" "url" => "/21735743/0000001000000003/v2_201406190029/S2173574313001366/v2_201406190029/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574314000148" "issn" => "21735743" "doi" => "10.1016/j.reumae.2013.09.001" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "604" "copyright" => "Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2014;10:194-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2344 "formatos" => array:3 [ "EPUB" => 52 "HTML" => 1814 "PDF" => 478 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Nodular Regenerative Hyperplasia of the Liver as a Complication of Long-standing Systemic-onset Juvenile Idiopathic Arthritis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "194" "paginaFinal" => "195" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hiperplasia nodular regenerativa hepática como complicación tardía de la artritis idiopática juvenil de inicio sistémico" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 345 "Ancho" => 1400 "Tamanyo" => 160504 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Liver biopsy in which a hyperplastic nodular zone (arrowheads) partially surrounded by dilated sinusoids (arrow) and absence of fibrosis (hematoxylin–eosin 2×) (A) is observed. At higher magnification, the sinusoids are compressed by the thickened hepatocyte plaques (hematoxylin–eosin 40×) (B). An abdominal CT scan shows dilation of the portal vein and its branches (arrow) (C).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Walter Alberto Sifuentes Giraldo, Ana Burdaspal Moratilla, Alberto Moreno Caparrós, María Luz Gámir Gámir" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Walter Alberto" "apellidos" => "Sifuentes Giraldo" ] 1 => array:2 [ "nombre" => "Ana" "apellidos" => "Burdaspal Moratilla" ] 2 => array:2 [ "nombre" => "Alberto" "apellidos" => "Moreno Caparrós" ] 3 => array:2 [ "nombre" => "María Luz" "apellidos" => "Gámir Gámir" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X1300199X" "doi" => "10.1016/j.reuma.2013.09.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X1300199X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314000148?idApp=UINPBA00004M" "url" => "/21735743/0000001000000003/v2_201406190029/S2173574314000148/v2_201406190029/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Reactivation of Hepatitis Virus B Infection in a Patient With Rheumatoid Arthritis After Treatment With Rituximab" "tieneTextoCompleto" => true "saludo" => "To the editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "196" "paginaFinal" => "197" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Tarek Carlos Salman-Monte, María Pilar Lisbona, Montserrat García-Retortillo, Joan Maymó" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Tarek Carlos" "apellidos" => "Salman-Monte" "email" => array:2 [ 0 => "tareto4@gmail.com" 1 => "98383@parcdesalutmar.cat" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "María Pilar" "apellidos" => "Lisbona" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Montserrat" "apellidos" => "García-Retortillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Joan" "apellidos" => "Maymó" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Reumatología, Parc de Salut Mar, Hospital del Mar, IMIM, Universidad Autónoma de Barcelona, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Sección de Hepatología, Parc de Salut Mar, Hospital del Mar, IMIM, Universidad Autónoma de Barcelona, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reactivación del virus de la hepatitis B en un paciente con artritis reumatoide tras el tratamiento con rituximab" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The reactivation of hepatitis B virus (HBV) infection is defined as an increase in HBV replication in a patient with an inactive or resolved hepatitis (usually accompanied by increased serum transaminase levels). Most reported cases have occurred in patients with hematologic malignancies after chemotherapy.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–3</span></a> Recently, there have been reports of HBV reactivation in patients with rheumatoid arthritis after treatment with biological therapies such as rituximab (RTX)<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Although most cases of HBV reactivation have occurred in patients with serology indicating chronic HBV infection, patients with resolved HBV infection can develop this complication.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">We report the case of a 77 year old patient with a history of seropositive and erosive rheumatoid arthritis of 12 years of evolution, receiving the first cycle of RTX in February 2008. Serology for HBV in 2001 was HBsAg negative and anti-HBc positive, compatible with resolved hepatitis B. The patient received methotrexate from 2002 to 2004 and the treatment was stopped by the appearance of oral ulcers. In 2005, treatment was started with infliximab 3<span class="elsevierStyleHsp" style=""></span>mg/kg every 8 weeks with good response; after one year of treatment, the patient presented a lack of response in March 2006 and it was suspended due to multiple episodes of lung infections and switched to etanercept 50<span class="elsevierStyleHsp" style=""></span>mg weekly. From 2005 to 2008, serum levels of ALT transaminase (GPT) ansd AST (GOT), remained stable, but new virus serology was not requested. Due to poor control of symptoms (disease activity score [DAS] 28 joints 6.43) the patient was treated with RTX (2×1000) in February 2008. He received the second cycle of RTX in August 2008. After treatment, the DAS 28 was 3.79, but in July 2009 the patient had anicteric hepatitis with ALT (GPT) 555<span class="elsevierStyleHsp" style=""></span>U/L, AST (GOT) 349<span class="elsevierStyleHsp" style=""></span>U/l, GGT 81<span class="elsevierStyleHsp" style=""></span>U/l, total bilirubin 0.7<span class="elsevierStyleHsp" style=""></span>mg/dl and HBsAg+, HBeAg+, albumin<span class="elsevierStyleHsp" style=""></span>35<span class="elsevierStyleHsp" style=""></span>mg/dl, 70% TP, 99<span class="elsevierStyleHsp" style=""></span>000<span class="elsevierStyleHsp" style=""></span>platelets/mm<span class="elsevierStyleSup">3</span> and HBV DNA was >8<span class="elsevierStyleHsp" style=""></span>log<span class="elsevierStyleHsp" style=""></span>U/ml (virus genotype was A). This data indicated the presence of a reactivation of chronic hepatitis B with a moderate degree of hepatocellular failure. At this point the patient quickly was sent to the hepatologist and began treatment with entecavir. After one month of therapy, HBV was DNA down to 5.4<span class="elsevierStyleHsp" style=""></span>log<span class="elsevierStyleHsp" style=""></span>U/ml. Five months later HBV-DNA was only 1.74<span class="elsevierStyleHsp" style=""></span>U/ml (3.24<span class="elsevierStyleHsp" style=""></span>log<span class="elsevierStyleHsp" style=""></span>U/ml), but remained positive until February 2011. The biochemical response was faster, with normalization of transaminases after only 8 months of therapy.</p><p id="par0015" class="elsevierStylePara elsevierViewall">HBV reactivation after immunosuppressive treatment is a serious adverse effect which can be identified and prevented. There have been various guidelines and recommendations but the management of HBV occult infection with only anti-HBc positivity remains unclear today.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7</span></a> The consensus on RTX use in rheumatoid arthritis recommends monitoring of transaminases and/or HBV DNA<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> in patients without active HBV with HBsAg negative but anti-HBc-positive antibodies, as in our patient. In patients who had increased levels of HBV DNA during therapy with RTX, one should consider associating antiretroviral therapy. The exact mechanism of HBV reactivation is unknown and although it is not a very common complication, there have been cases of fulminant hepatitis that were seen even after 6 months of cessation of therapy with RTX.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> Prophylactic treatment with antiretroviral therapy significantly reduces the incidence of HBV reactivation after treatment with RTX.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> In conclusion, strict monitoring should follow liver biochemistry, HBsAg, HBV-DNA in the anti-HBc positive and HBsAg negative patients during and 6 months after treatment with RTX.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Salman-Monte TC, Lisbona MP, García-Retortillo M, Maymó J. Reactivación del virus de la hepatitis B en un paciente con artritis reumatoide tras el tratamiento con rituximab. Reumatol Clin. 2014;10:196–197.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">F: female, M: male.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Reference \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Patient \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">No. cycles RTX \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">HBV serology before RTX \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">HBV serology after RTX \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Antiretroviral therapy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Evolution \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pyrpasopoulou et al.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">F 56 RA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Only RTX \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HBsAg+ HBeAg+ HBeAb− HBV DNA>9.6×10<span class="elsevierStyleSup">2</span><span class="elsevierStyleHsp" style=""></span>U/ml Normal serum transaminases treatment with lamivudine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HBsAg+ HBeAg+ HBV DNA>1.1×10<span class="elsevierStyleSup">8</span><span class="elsevierStyleHsp" style=""></span>U/ml ASAT 110<span class="elsevierStyleHsp" style=""></span>U/l ALT 150<span class="elsevierStyleHsp" style=""></span>U/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tenofovir and lamivudine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 months later HBV load was 46<span class="elsevierStyleHsp" style=""></span>U/ml \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ghrénassia et al.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M 78 RA and mantle cell lymphoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RTX+prednisone 10<span class="elsevierStyleHsp" style=""></span>mg/day \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HBsAg HBcAb+normal serum transaminases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HBsAg +HBeAg+ HBV DNA<span class="elsevierStyleMonospace">></span>7<span class="elsevierStyleHsp" style=""></span>log<span class="elsevierStyleHsp" style=""></span>U/ml ASAT 177<span class="elsevierStyleHsp" style=""></span>U/l ALT 421<span class="elsevierStyleHsp" style=""></span>U/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Entecavir \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 months later HBV load was undetectable \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Case \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M 77 RA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RTX+prednisone<span class="elsevierStyleHsp" style=""></span>15<span class="elsevierStyleHsp" style=""></span>mg/day \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HBsAg HBcAb+normal serum transaminases \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HBsAg+ HBeAg+ HBV DNA>8<span class="elsevierStyleHsp" style=""></span>log<span class="elsevierStyleHsp" style=""></span>U/ml ASAT 349<span class="elsevierStyleHsp" style=""></span>U/l ALT 555<span class="elsevierStyleHsp" style=""></span>U/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Entecavir \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18 months later HBV load was undetectable \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab517346.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Previous Cases of HBV Reactivation in RA Patients Following Treatment With RTX.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:5 [ 0 => "W. Yeo" 1 => "T.C. Chan" 2 => "N.W.Y. Leung" 3 => "F.K.F. Lam WY, Mo" 4 => "M.T. Chu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2008.18.0182" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2008" "volumen" => "27" "paginaInicial" => "605" "paginaFinal" => "611" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19075267" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reactivation of hepatitis B virus during RTX treatment of a patient with follucilar limphoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.H. Yang" 1 => "S.H. Kuo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Haematol" "fecha" => "2008" "volumen" => "87" "paginaInicial" => "325" "paginaFinal" => "327" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Pei" 1 => "C. Chen" 2 => "C. Lee" 3 => "M. Wang" 4 => "M. Ma" 5 => "T.H. Hu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00277-009-0806-7" "Revista" => array:6 [ "tituloSerie" => "Ann Hematol" "fecha" => "2010" "volumen" => "89" "paginaInicial" => "255" "paginaFinal" => "262" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19697028" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Pyrpasoppoulou" 1 => "S. Douma" 2 => "T. Vassiliadis" 3 => "S. Chatzimichailidou" 4 => "A. Triantafyllou" 5 => "S. Aslanidis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00296-009-1202-2" "Revista" => array:6 [ "tituloSerie" => "Rheumatol Int" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "403" "paginaFinal" => "404" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19830433" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Ghrénassia" 1 => "A. Méknian" 2 => "S. Rouaghe" 3 => "N. Granne" 4 => "O. Fain" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jbspin.2011.07.003" "Revista" => array:6 [ "tituloSerie" => "Joint Bone Spine" "fecha" => "2012" "volumen" => "79" "paginaInicial" => "100" "paginaFinal" => "101" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21944979" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis B virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.M. Nathan" 1 => "P.W. Angus" 2 => "P.R. Gibson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1746.2006.04559.x" "Revista" => array:6 [ "tituloSerie" => "J Gastroenterol Hepatol" "fecha" => "2006" "volumen" => "21" "paginaInicial" => "1366" "paginaFinal" => "2137" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16911678" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Yazdany" 1 => "L. Calabrese" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthritis Care Res (Hoboken)" "fecha" => "2010" "volumen" => "62" "paginaInicial" => "585" "paginaFinal" => "589" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.H. Buch" 1 => "J.S. Smolen" 2 => "N. Betteridge" 3 => "F.C. Breedveld" 4 => "G. Burmester" 5 => "T. Dörner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/ard.2010.144998" "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2011" "volumen" => "70" "paginaInicial" => "909" "paginaFinal" => "920" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21378402" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab administration and reactivation of HBV" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Tsutsumi" 1 => "R. Ogasawara" 2 => "Y. Kamihara" 3 => "S. Ito" 4 => "Y. Yamamoto" 5 => "J. Tanaka" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Hepatitis Res Treat" "fecha" => "2010" "volumen" => "2010" "paginaInicial" => "182067" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y.X. Koo" 1 => "D.S. Tan" 2 => "B.H. Tan" 3 => "R. Quek" 4 => "M. Tao" 5 => "S.T. Lim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2009.21.9352" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "2570" "paginaFinal" => "2571" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19364951" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001000000003/v2_201406190029/S217357431300138X/v2_201406190029/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001000000003/v2_201406190029/S217357431300138X/v2_201406190029/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357431300138X?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 6 | 11 |
2024 October | 29 | 28 | 57 |
2024 September | 42 | 27 | 69 |
2024 August | 53 | 28 | 81 |
2024 July | 43 | 46 | 89 |
2024 June | 58 | 25 | 83 |
2024 May | 54 | 32 | 86 |
2024 April | 62 | 30 | 92 |
2024 March | 50 | 25 | 75 |
2024 February | 37 | 26 | 63 |
2024 January | 37 | 23 | 60 |
2023 December | 40 | 31 | 71 |
2023 November | 34 | 27 | 61 |
2023 October | 37 | 27 | 64 |
2023 September | 66 | 31 | 97 |
2023 August | 28 | 11 | 39 |
2023 July | 34 | 23 | 57 |
2023 June | 44 | 19 | 63 |
2023 May | 38 | 26 | 64 |
2023 April | 17 | 5 | 22 |
2023 March | 47 | 38 | 85 |
2023 February | 37 | 27 | 64 |
2023 January | 21 | 18 | 39 |
2022 December | 42 | 34 | 76 |
2022 November | 42 | 29 | 71 |
2022 October | 36 | 32 | 68 |
2022 September | 36 | 44 | 80 |
2022 August | 32 | 35 | 67 |
2022 July | 34 | 43 | 77 |
2022 June | 31 | 34 | 65 |
2022 May | 46 | 30 | 76 |
2022 April | 38 | 50 | 88 |
2022 March | 38 | 34 | 72 |
2022 February | 39 | 24 | 63 |
2022 January | 31 | 31 | 62 |
2021 December | 28 | 39 | 67 |
2021 November | 40 | 44 | 84 |
2021 October | 32 | 49 | 81 |
2021 September | 30 | 38 | 68 |
2021 August | 28 | 34 | 62 |
2021 July | 30 | 27 | 57 |
2021 June | 33 | 45 | 78 |
2021 May | 37 | 20 | 57 |
2021 April | 85 | 62 | 147 |
2021 March | 49 | 34 | 83 |
2021 February | 28 | 20 | 48 |
2021 January | 19 | 12 | 31 |
2020 December | 41 | 22 | 63 |
2020 November | 27 | 14 | 41 |
2020 October | 17 | 15 | 32 |
2020 September | 35 | 29 | 64 |
2020 August | 17 | 24 | 41 |
2020 July | 20 | 29 | 49 |
2020 June | 31 | 30 | 61 |
2020 May | 24 | 13 | 37 |
2020 April | 22 | 15 | 37 |
2020 March | 16 | 11 | 27 |
2018 May | 4 | 2 | 6 |
2018 April | 43 | 5 | 48 |
2018 March | 36 | 7 | 43 |
2018 February | 29 | 9 | 38 |
2018 January | 23 | 4 | 27 |
2017 December | 26 | 6 | 32 |
2017 November | 29 | 5 | 34 |
2017 October | 21 | 3 | 24 |
2017 September | 29 | 5 | 34 |
2017 August | 39 | 6 | 45 |
2017 July | 47 | 5 | 52 |
2017 June | 53 | 10 | 63 |
2017 May | 49 | 11 | 60 |
2017 April | 33 | 7 | 40 |
2017 March | 20 | 9 | 29 |
2017 February | 15 | 4 | 19 |
2017 January | 29 | 6 | 35 |
2016 December | 51 | 14 | 65 |
2016 November | 24 | 4 | 28 |
2016 October | 58 | 9 | 67 |
2016 September | 52 | 6 | 58 |
2016 August | 43 | 5 | 48 |
2016 July | 28 | 4 | 32 |
2015 December | 1 | 0 | 1 |
2015 November | 2 | 0 | 2 |
2015 September | 2 | 0 | 2 |
2015 August | 1 | 0 | 1 |
2015 July | 16 | 7 | 23 |
2015 June | 33 | 5 | 38 |
2015 May | 53 | 7 | 60 |
2015 April | 70 | 10 | 80 |
2015 March | 44 | 12 | 56 |
2015 February | 38 | 9 | 47 |
2015 January | 57 | 10 | 67 |
2014 December | 35 | 9 | 44 |
2014 November | 33 | 11 | 44 |
2014 October | 35 | 10 | 45 |
2014 September | 22 | 10 | 32 |
2014 August | 31 | 12 | 43 |
2014 July | 47 | 15 | 62 |
2014 June | 52 | 19 | 71 |
2014 May | 29 | 14 | 43 |